title: Eosinophilic phenotypes of airway disease.
abstract: Our understanding of the clinical implications of eosinophilic airway inflammation has increased significantly over the last 20 years, aided by the development of noninvasive means to assess it. This pattern of airway inflammation can occur in a diverse range of airway diseases. It is associated with a positive response to corticosteroids and a high risk of preventable exacerbations. Our new understanding of the role of eosinophilic airway inflammation has paved the way for the clinical development of a number of more specific inhibitors that may become new treatment options. Different definitions, ideas of disease, and adoption of biomarkers that are not well known are necessary to fully realize the potential of these treatments.
authors: Department of Respiratory Medicine and Thoracic Surgery, Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
authors: Ian D
authors: ID
authors: Pavord
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000276:immunology*; D016535:Bronchial Hyperreactivity / Q000276:immunology; D001991:Bronchitis / Q000188:drug therapy / Q000276:immunology; D004802:Eosinophilia / Q000188:drug therapy / Q000276:immunology*; D004804:Eosinophils / Q000166:cytology / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D008168:Lung / Q000276:immunology*; D010641:Phenotype; D013183:Sputum / Q000166:cytology; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones